Introduction: The totally implantable active middle ear implant Esteem® may be considered an effective alternative to conventional hearing aids (cHAs) to manage moderate-to-severe forms of sensorineural hearing loss. This study aimed to provide long-term comparative data of Esteem performances with those achieved by cHA. Methods: From a total of 46 subjects who received unilateral application of Esteem®, and were followed up over the years, ten underwent an audiological assessment that compared the outcomes with those achieved in the contralateral ear by a cHA, considering the initially symmetric auditory thresholds in both ears. Other than pure tone audiometry and speech audiometry in quiet, the assessment was performed by using the adaptive speech in noise, i.e., Matrix test. Results: The mean speech intelligibility in quiet shows in the unaided situation a recognition of 50.7% at 71 dBHL, 71% at 69 dBHL with only contralateral cHA, 92% at 66 dBHL with only Esteem device and 94% at 61 dBHL with Esteem® device and contralateral cHA. The mean speech intelligibility in noise shows in the unaided situation a recognition of 36% at 71 dBHL, 56% at 69 dBHL with only contralateral cHA, 79% at 66 dBHL with only Esteem® device and 84% at 61 dBHL with Esteem® device and contralateral cHA. At Matrix test in the unaided condition, 4 patients reached 50% of intelligibility and the 50% threshold was obtained with a mean sound/noise ratio of +10 dBHL. In the contralaterally aided condition, 10 patients reached a 50% threshold in a condition of mean S/N ratio of +10.6 dBHL. In the Esteem® only and Esteem® plus cHA condition, all patients reached the 50% threshold with a mean S/N ratio of +3.4 dBHL with the Esteem® device and +0.92 dBHL with Esteem® plus a contralateral cHA, with a statistically nonsignificant difference. The mean deviation from the reference value (7.1 dB in the normal hearing population) was 17.1 dBHL, in unaided situation; this condition did not change with only the contralateral cHA (17.6 dBHL), whilst a significant improvement could be identified with only Esteem® device, where the mean deviation was 10.5 dBHL, and mostly with Esteem® device associated with the contralateral cHA, with a value of 8.02 dBHL. Conclusions: The adaptive speech audiometry in noise (Matrix Test) showed that binaural stimulation provides greater benefits in the speech recognition in noise test in comparison to monaural stimulation, especially when this is carried out only by the cHA. However, the Esteem® device allowed to obtain audiological benefits that are significantly superior to those offered by cHAs, especially in cases where the hearing loss is severe and, in some cases, profound, achieving performances almost comparable to those of a cochlear implant.

1.
Barbara
M
,
Biagini
M
,
Monini
S
.
The totally implantable middle ear device “Esteem” for rehabilitation of severe sensorineural hearing loss
.
Acta Otolaryngol
.
2011
;
131
(
4
):
399
404
.
2.
Marzo
SJ
,
Sappington
JM
,
Shohet
JA
.
The Envoy Esteem implantable hearing system
.
Otolaryngol Clin North Am
.
2014
;
47
(
6
):
941
52
.
3.
Monini
S
,
Biagini
M
,
Atturo
F
,
Barbara
M
.
Esteem® middle ear device versus conventional hearing aids for rehabilitation of bilateral sensorineural hearing loss
.
Eur Arch Oto-Rhino-Laryngol
.
2013
;
270
(
7
):
2027
33
.
4.
Seidman
MD
,
Janz
TA
,
Shohet
JA
.
Totally implantable active middle ear implants
.
Otolaryngol Clin North Am
.
2019
;
52
(
2
):
297
309
.
5.
Maassen
MM
,
Rodriguez Jorge
J
,
Herberhold
S
,
Vonthein
R
,
Zimmermann
R
,
Baumann
I
, et al
.
Safe and reliable sound threshold measures with direct vibration of the ossicular chain
.
Laryngoscope
.
2004
;
114
(
11
):
2012
20
.
6.
Barbara
M
,
Manni
V
,
Monini
S
.
Totally implantable middle ear device for rehabilitation of sensorineural hearing loss: preliminary experience with the Esteem, Envoy
.
Acta Otolaryngol
.
2009
;
129
(
4
):
429
32
.
7.
Banakis Hartl
RM
,
Jenkins
HA
.
Implantable hearing aids: where are we in 2020
.
Laryngoscope Investig Otolaryngol
.
2020
;
5
(
6
):
1184
91
.
8.
Bruschini
L
,
Berrettini
S
,
Forli
F
,
Murri
A
,
Cuda
D
.
The Carina© middle ear implant: surgical and functional outcomes
.
Eur Arch Oto-Rhino-Laryngol
.
2016
;
273
(
11
):
3631
40
.
9.
Kraus
EM
,
Shohet
JA
,
Catalano
PJ
.
Envoy esteem totally implantable hearing system: phase 2 trial, 1-year hearing results
.
Otolaryngol Head Neck Surg
.
2011
;
145
(
1
):
100
9
.
10.
Puglisi
GE
,
di Berardino
F
,
Montuschi
C
,
Sellami
F
,
Albera
A
,
Zanetti
D
, et al
.
Evaluation of Italian simplified matrix test for speech-recognition measurements in noise
.
Audiol Res
.
2021
;
11
(
1
):
73
88
.
11.
Schraven
SP
,
Hirt
B
,
Goll
E
,
Heyd
A
,
Gummer
AW
,
Zenner
HP
, et al
.
Conditions for highly efficient and reproducible round-window stimulation in humans
.
Audiol Neurootol
.
2012
;
17
(
2
):
133
8
.
12.
Altuna Mariezcurrena
X
,
Algaba Guimerá
J
,
Bolinaga Zubizarreta
U
.
The esteem hearing implant by envoy medical
.
Acta Otorrinolaringol Esp
.
2008
;
59
(
Suppl 1
):
33
4
.
13.
Marzo
SJ
,
Sappington
JM
,
Shohet
JA
.
The Envoy Esteem implantable hearing system
.
Otolaryngol Clin North Am
.
2014
;
47
(
6
):
941
52
.
14.
Barbara
M
,
Filippi
C
,
Tarentini
S
,
Covelli
E
,
Monini
S
.
Rehabilitation of severe-to-profound sensorineural hearing loss with an active middle ear implant
.
Acta Otolaryngol
.
2020
;
140
(
3
):
236
41
.
15.
Bruschini
L
,
Canzi
P
,
Canale
A
,
Covelli
E
,
Laborai
A
,
Monteforte
M
, et al
.
Implantable hearing devices in clinical practice. Systematic review and consensus statements
.
Acta Otorhinolaryngol Ital
.
2024
;
44
(
1
):
52
67
.
16.
Monini
S
,
Bianchi
A
,
Talamonti
R
,
Atturo
F
,
Filippi
C
,
Barbara
M
.
Patient satisfaction after auditory implant surgery: ten-year experience from a single implanting unit center
.
Acta Otolaryngol
.
2017
;
137
(
4
):
389
97
.
17.
Gerard
JM
,
Thill
MP
,
Chantrain
G
,
Gersdorff
M
,
Deggouj
N
.
Esteem 2 middle ear implant: our experience
.
Audiol Neurootol
.
2012
;
17
(
4
):
267
74
.
18.
Shohet
JA
,
Kraus
EM
,
Catalano
PJ
,
Toh
E
.
Totally implantable hearing system: five-year hearing results
.
Laryngoscope
.
2018
;
128
(
1
):
210
6
.
19.
Barbara
M
,
Filippi
C
,
Covelli
E
,
Volpini
L
,
Monini
S
.
Ten years of active middle ear implantation for sensorineural hearing loss
.
Acta Otolaryngol
.
2018
;
138
(
9
):
807
14
.
20.
Monini
S
,
Filippi
C
,
Salerno
G
,
Barbara
M
.
Long-term follow-up of the auditory threshold after a fully implantable middle ear implant
.
Front Neurol
.
2022
;
13
:
834402
.
21.
Barbara
M
,
Covelli
E
,
Filippi
C
,
Volpini
L
,
Monini
S
.
Revision of active middle ear implants (AMEI): causes, surgical issues and r-ehabilitative transition at a single implanting center
.
Eur Arch Oto-Rhino-Laryngol
.
2021
;
278
(
11
):
4289
94
.
22.
Liu
H
,
Cheng
J
,
Yang
J
,
Rao
Z
,
Cheng
G
,
Yang
S
, et al
.
Concept and evaluation of a new piezoelectric transducer for an implantable middle ear hearing device
.
Sensors
.
2017
;
17
(
11
):
2515
.
23.
Barbara
M
,
Margani
V
,
Volpini
L
,
Filippi
C
,
Covelli
E
,
Monini
S
, et al
.
On the battery life of a totally implantable active middle ear device: a retrospective study in a single implanting center
.
Acta Otolaryngol
.
2023
;
143
(
1
):
6
11
.
You do not currently have access to this content.